For the quarter ending 2026-03-31, NXTC has $37,977K in assets. $11,261K in debts. $15,167K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 15,167 | 25,982 | 7,324 | 4,892 |
| Marketable securities | 14,576 | 15,836 | 21,786 | 30,416 |
| Prepaid expenses and other current assets | 1,998 | 1,929 | 3,530 | 4,707 |
| Total current assets | 31,741 | 43,747 | 32,640 | 40,015 |
| Property and equipment, net | 2,990 | 3,273 | 3,638 | 4,171 |
| Right of use assets | 2,399 | 2,617 | 2,785 | 2,948 |
| Other assets | 847 | 546 | 550 | 555 |
| Total assets | 37,977 | 50,183 | 39,613 | 47,689 |
| Accounts payable | 3,070 | 2,011 | 2,391 | 2,544 |
| Accrued liabilities and other liabilities | 3,821 | 8,555 | 8,604 | 8,237 |
| Total current liabilities | 6,891 | 10,566 | 10,995 | 10,781 |
| Lease liabilities, long term | 3,879 | 4,148 | 4,411 | 4,666 |
| Other long-term liabilities | 491 | 526 | 561 | 596 |
| Total liabilities | 11,261 | 15,240 | 15,967 | 16,043 |
| Common stock, par value of 0.001 per share 100,000,000 shares authorized at march 31, 2026 and december 31, 2025 3,607,555 and 3,505,621 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 4 | 4 | 3 | 2 |
| Additional paid-in capital | 472,490 | 470,898 | 450,170 | 447,571 |
| Accumulated other comprehensive (loss) income | -2 | 21 | 17 | -7 |
| Accumulated deficit | -445,776 | -435,980 | -426,544 | -417,920 |
| Total stockholders' equity | 26,716 | 34,943 | 23,646 | 29,646 |
| Common stock, par value of 0.001 per share 100,000,000 shares authorized at june 30, 2025 and december 31, 2024 338,636 and 0 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively | - | - | - | 2,000 |
| Total liabilities and stockholders' equity | 37,977 | 50,183 | 39,613 | 47,689 |
NextCure, Inc. (NXTC)
NextCure, Inc. (NXTC)